Shingles Vaccine May Reduce Heart Attack and Stroke Risk, Study Suggests

Shingles Vaccine and Cardiovascular Health

• 💡 A recent study published in the European Heart Journal suggests the shingles vaccine may decrease the incidence of heart attacks and strokes.
• 🎯 The study followed a million adults over eight years, finding that those who received the Zostavax shingles vaccine had a 23% lower chance of heart attacks and strokes.

Understanding the Mechanism

• 🧠 The varicella zoster virus, which causes shingles, remains dormant in the body for decades and may adversely affect the heart and blood vessels.
• ⚠️ It is theorized that the chronic inflammation caused by the virus could increase the risk of cardiovascular events.
• ✅ Vaccines may help mitigate these risks by reducing inflammation.

Vaccine Efficacy and Evolution

• 📈 While Zostavax was previously used, it has been replaced by the Shingrix vaccine in the US due to its longer-lasting effectiveness and higher efficacy.
• 🚀 The Shingrix vaccine is expected to be more effective against the inflammation linked to heart attacks and strokes.

Broader Implications of Viral Infections

• 🦠 Viruses are implicated in a range of health issues beyond their primary infections, including cancers (Hepatitis C, HPV) and neurological effects (COVID-19 brain fog).
• 🧩 The shingles virus may also contribute to certain forms of dementia.
• ✨ This research highlights the broader benefits of vaccines in addressing not only infections but also potential long-term health complications.